钙拮抗剂治疗肝纤维化的亚细胞学研究
*卫生部青年基金资助课题No.92235,项目负责人,Thesubcellularstudyofcalciumantagonistsintreatmentofhepatofibrosis,Abstract,AIMS,METHODS,RESULTS,CONCLUSIONS,Keywords,摘要,目的,关键词,1材料和方法,2结果,表,2,3,3讨论,4参考文献
*卫生部青年基金资助课题No.922351北京医科大学人民医院肝病研究所 北京市 100044
2上海第二医科大学新华医院消化研究室 200092
项目负责人 刘玉兰 北京医科大学人民医院肝病研究所 北京市 100044
收稿日期 1995-05-15
The subcellular study of calcium antagonists in treatment of hepatofibrosis
Yu-Lan Liu1,Ding-Guo Li2,Han-Ming Lu 2, Zu-Ming Jiang2 and Qin-Fang Xu 2
1Institute of hepatology, People's Hospital of Beijing Medical university, Beijing 100044 China
2Gastroenterology Research Unit, Xinhua Hospital of Shanghai Second Medical University, Shanghai 200092 China
Abstract
AIMS The effects of calcium antagonists (Ca-A) on hepatofibrosis of rats were studied in subcellular level.
METHODS Hepatofibrosis model was induced in Wistar rats with 40% CCl4 0.5 ml/per rat SC, once every three days for 15 times. Then different doses of tetrandrine, verapamil, nifedipine and cinnarizine were used to treat these rats in the early and late hepatofibrotic stages. Mitochondria and inner membrane were separated, MAO and N-acety β - glucosaminidase(NAG) activities were assayed, and mitochondrial inner memeberane superfical and paracentral fuidities were detected. ......
您现在查看是摘要页,全文长 10556 字符。